Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
26 studies found for:    Trabectedin | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Retrospective Study of Trabectedin in Soft Tissue Sarcomas
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Trabectedin
2 Recruiting Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma
Conditions: Liposarcoma;   Leiomyosarcoma
Intervention: Drug: Trabectedin
3 Recruiting ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: Trabectedin
4 Recruiting Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin
Condition: Sarcoma
Interventions: Drug: Trabectedin;   Genetic: DNA double-strand breaks
5 Recruiting Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Intervention: Drug: trabectedin
6 Not yet recruiting Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26
Conditions: Carcinosarcoma, Ovarian;   Carcinosarcomas Uterine
Intervention: Drug: Trabectedin
7 Not yet recruiting Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.
Conditions: Ovarian Carcinoma;   Soft Tissue Sarcoma
Intervention: Drug: Combination of trabectedin with durvalumab
8 Recruiting Trabectedin for Recurrent Grade II/III Meningioma
Condition: Recurrent High Grade Meningioma
Interventions: Drug: Trabectedin;   Other: Local standard of care
9 Recruiting Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer
Condition: Ovarian Epithelial Cancer Recurrent
Interventions: Drug: bevacizumab and trabectedin;   Drug: bevacizumab, trabectedin and carboplatin
10 Not yet recruiting Trabectedin Maintenance Post 1st-line in STS
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Trabectedin
11 Recruiting Phase I-II Trial, Multicenter, Open, Exploring Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
Conditions: Liposarcoma, Myxoid;   Sarcoma, Soft Tissue
Interventions: Drug: Trabectedin;   Radiation: Radiotherapy
12 Recruiting Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide
Condition: Soft-tissue Sarcomas
Interventions: Drug: Phase 1: Trabectedin;   Drug: Phase 2: Trabectedin;   Drug: Phase 1: Cyclophosphamide;   Drug: Phase 2: Cyclophosphamide
13 Not yet recruiting Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery
Conditions: Metastatic Leiomyosarcoma;   Metastatic Liposarcoma
Interventions: Drug: Avelumab;   Other: Laboratory Biomarker Analysis;   Drug: Trabectedin
14 Recruiting Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients
Condition: Relapsed Ovarian Cancer
Intervention: Drug: trabectedin
15 Recruiting Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma
Condition: Soft Tissue Sarcoma
Interventions: Drug: Trabectedin;   Drug: Dexamethasone
16 Not yet recruiting Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors
Condition: Cancers With DNA Repair-Deficiency
Interventions: Drug: Olaparib;   Drug: Physician's choice;   Drug: Trabectedin
17 Not yet recruiting Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor
Condition: Solitary Fibrous Tumors
Interventions: Drug: Trabectedin;   Drug: Adriamycin;   Drug: Dacarbazine
18 Recruiting Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients _MITO-23
Condition: Ovarian Neoplasms
Interventions: Drug: Trabectedin;   Drug: Pegylated Liposomal Doxorubicin;   Drug: Topotecan;   Drug: Gemcitabine;   Drug: Weekly Paclitaxel;   Drug: Carboplatin
19 Not yet recruiting Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma
Condition: Uterine or Soft Tissue Leiomyosarcoma
Interventions: Drug: Doxorubicin;   Drug: Trabectedin
20 Recruiting A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Ovarian Neoplasms;   Peritoneal Neoplasms;   Fallopian Tube Neoplasms
Interventions: Drug: Trabectedin;   Drug: DOXIL;   Drug: Dexamethasone

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.